FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061370 [Registered on: 11/01/2024] Trial Registered Prospectively
Last Modified On: 08/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Probiotic 
Study Design  Other 
Public Title of Study   Role of Probiotics in acute diarrhea in children of age 6 months to 5 years. 
Scientific Title of Study   Safety and Efficacy of saccharomyces boulardii (CNCM I-745) in acute diarrhea in children of age 6 months to 5 years.A Randomized Double blind controlled study. 
Trial Acronym  RCT 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Kumari Akanksha Rani 
Designation  PG Resident 
Affiliation  Geetanjali Medical College and Hospital 
Address  I block Pediatric OPD 1st floor

Udaipur
RAJASTHAN
313002
India 
Phone  8001715381  
Fax    
Email  aks08kar1712@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SANJAY MANDOT 
Designation  PROFESSOR AND UNIT HEAD 
Affiliation  Geetanjali Medical College and Hospital 
Address  I3 BLOCK PEDIATRIC OPD 1ST FLOOR GEETANJALI MEDICAL COLLEGE AND HOSPITAL UDAIPUR RAJASTHAN

Udaipur
RAJASTHAN
313002
India 
Phone  9462022900  
Fax    
Email  drmandot@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DR SANJAY MANDOT 
Designation  PROFESSOR AND UNIT HEAD 
Affiliation  Geetanjali Medical College and Hospital 
Address  I3 BLOCK PEDIATRIC OPD 1ST FLOOR GEETANJALI MEDICAL COLLEGE AND HOSPITAL UDAIPUR

Udaipur
RAJASTHAN
313002
India 
Phone  9462022900  
Fax    
Email  drmandot@yahoo.com  
 
Source of Monetary or Material Support  
Geetanjali Medical College and Hospital Manvakheda Udaipur Rajasthan 
 
Primary Sponsor  
Name  Kumari Akanksha Rani 
Address  Room no 555 Old PG hostel GMCH,Udaipur 
Type of Sponsor  Other [PG RESIDENT] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Kumari Akanksha Rani  Geetanjali Medical College and Hospital  Room I-2 Pediatric OPD 1st floor Geetanjali Hospital
Udaipur
RAJASTHAN 
8001715381

aks08kar1712@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Human Research Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K928||Other specified diseases of the digestive system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Saccharomyces boulardii (CNCM I-745) treated group   The amount,consistency and frequency of stool will analyzed for efficacy and adverse effects will be noted for safety those treated with Saccharomyces boulardii sachet . 
Comparator Agent  Standard medical treatment (SMT) group   The amount, consistency and frequency of stool will analyzed those treated with standard medical treatment(SMT).  
 
Inclusion Criteria  
Age From  6.00 Month(s)
Age To  5.00 Year(s)
Gender  Both 
Details  All the children age between 6 months to 5 years attending out patient department of Pediatrics with diagnosis of acute diarrhea. 
 
ExclusionCriteria 
Details  History of presence of blood in stool,Clinical signs of severe malnutrition,Clinical signs of severe dehydration,Treatment with antibiotics/probiotics,Coexisting acute systemic illness 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1.To evaluate safety and efficacy of saccharomyces boulardii in acute diarrhea in children of age 6 months to 5 years.  On day 3 and day 6 
 
Secondary Outcome  
Outcome  TimePoints 
To analyse other associated clinical features in acute diarrhea.  on day 3 and day 6 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   18/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is Randomized Controlled Trial to evaluate safety and efficacy of Saccharomyces Boulardii (CNCM I-745) in acute diarrhea in children of age 6 months to 5 years.Study will be conducted at Geetanjali hospital ,UDAIPUR. 
Close